Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/08/2014US20140128474 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE
05/08/2014US20140128473 Method of treating non-alcoholic steatohepatitis
05/08/2014US20140128472 Treatment and prevention of diseases related to oxidative stress
05/08/2014US20140128470 Acetylcysteine Composition and Uses Thereof
05/08/2014US20140128468 Topical film-forming composition, and use thereof for treating mycoses
05/08/2014US20140128464 Compositions and methods for treating and/or preventing cardiovascular disease
05/08/2014US20140128462 Lyophilized preparation of cytotoxic dipeptides
05/08/2014US20140128461 Use of a food composition in the treatment and/or prevention of neuropathic pain induced by an anticancer agent
05/08/2014US20140128460 Use of small molecule inhibitors targeting eya tyrosine phosphatase
05/08/2014US20140128454 Nucleic acid modulators of glycoprotein vi
05/08/2014US20140128453 Modulation of apolipoprotein ciii (apociii) expression
05/08/2014US20140128451 Compositions and Methods for Delivery of MicroRNA to Cells
05/08/2014US20140128450 Cancer Therapy
05/08/2014US20140128445 Polymeric benzyl carbonate-derivatives
05/08/2014US20140128443 Liquid Formulations Of Bendamustine
05/08/2014US20140128439 Methods for Treating Gout Flares
05/08/2014US20140128438 Methods for Treating Gout Flares
05/08/2014US20140128434 Method of administration and treatment
05/08/2014US20140128433 Methods for the administration of iloperidone
05/08/2014US20140128432 Anaplastic thyroid cancers harbor novel oncogenic mutations of the alk gene
05/08/2014US20140128431 Pharmaceutical composition with improved bioavailability, safety and tolerability
05/08/2014US20140128425 Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128424 Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
05/08/2014US20140128422 New therapeutical composition containing apomorphine as active ingredient
05/08/2014US20140128420 Nutritional supplement compositions
05/08/2014US20140128416 Medical devices incorporating collagen inhibitors
05/08/2014US20140128412 Combination of an antipsychotic and an anti-inflammatory agent
05/08/2014US20140128409 Medicaments for the treatment or prevention of fibrotic diseases
05/08/2014US20140128408 Hdac inhibitors and therapeutic methods using the same
05/08/2014US20140128407 Fast dissolving azaperone granulate formulation
05/08/2014US20140128405 Composition and use for phosphodiesterase inhibitors
05/08/2014US20140128402 Pharmaceutical combination
05/08/2014US20140128401 8-fluorophthalazin-1(2h)-one compounds
05/08/2014US20140128399 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp
05/08/2014US20140128396 Pyrimidinyl pyridazinone derivatives
05/08/2014US20140128395 Novel Method
05/08/2014US20140128392 Heterocyclic compounds for the inhibition of pask
05/08/2014US20140128390 Compounds and methods for kinase modulation, and indications therefor
05/08/2014US20140128389 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
05/08/2014US20140128387 Certain protein kinase inhibitors
05/08/2014US20140128386 Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128385 Bace-2 inhibitors for the treatment of metabolic disorders
05/08/2014US20140128383 Inhibitors of viral replication, their process of preparation and their therapeutical uses
05/08/2014US20140128382 5-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use
05/08/2014US20140128381 Intranasal Benzodiazepine Pharmaceutical Compositions
05/08/2014US20140128379 Nasal formulations of benzodiazepine
05/08/2014US20140128378 Methods of treating epileptogenesis
05/08/2014US20140128377 Methods of treating refractory repetitive seizures
05/08/2014US20140128375 Benzazepine compounds as cgrp receptor antagonists
05/08/2014US20140128373 Compounds and methods for kinase modulation, and indications therefor
05/08/2014US20140128372 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/2014US20140128367 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
05/08/2014US20140128365 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
05/08/2014US20140128364 Therapeutic uses of tigemonam and carumonam
05/08/2014US20140128361 Cyclic amide bace-1 inhibitors having a benzamide substituent
05/08/2014US20140128356 Na/K-ATPase Ligand
05/08/2014US20140128355 Baclofen solution for low-volume therapeutic delivery
05/08/2014US20140128354 Compositions and Methods for Treating Severe Pain
05/08/2014US20140128353 Solid Solution Compositions and Use in Cardiovascular Disease
05/08/2014US20140128352 Compounds and methods for modulating mitochondrial metabolism and reactive oxygen species production
05/08/2014US20140128351 Combination therapy for skin disorders
05/08/2014US20140128350 Substituted Pyridine Derivatives Useful In The Treatment Of Cancer
05/08/2014US20140128349 Administering inhibitors of tgfbeta signaling in combination with benzothiazepine derivatives to improve muscle function in cancer patients
05/08/2014US20140128345 Vaginal matrices: nanofibers for contraception and prevention of hiv infection
05/08/2014US20140128342 Composition comprising at least one alginate for use in treatment and/or prevention of overweight
05/08/2014US20140128341 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha
05/08/2014US20140128340 Pharmaceutical compositions comprising modified fucans and methods relating thereto
05/08/2014US20140128339 2'-methyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
05/08/2014US20140128337 Curcuminoids in Combination Docetaxel for the Treatment of Cancer and Tumour Metastasis
05/08/2014US20140128336 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
05/08/2014US20140128335 Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment
05/08/2014US20140128333 Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release
05/08/2014US20140128332 Ngna compositions and methods of use
05/08/2014US20140128329 Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers
05/08/2014US20140128327 Dendrimer conjugates
05/08/2014US20140128322 Compositions for Controlling Neuronal Outgrowth
05/08/2014US20140128315 Caspofungin or salts thereof with high purity, as well as preparation method and use thereof
05/08/2014US20140127328 Methods and compositions for treating anxiety disorders or symptoms thereof
05/08/2014US20140127327 Preserved topical formulations with improved antimicrobial activity
05/08/2014US20140127325 Compositions and Method for Inhibiting Hepcidin Antimicrobial Peptide (HAMP) or HAMP-Related Gene Expression
05/08/2014US20140127320 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/08/2014US20140127316 Propolis and caffeic acid phenethyl ester and uses thereof
05/08/2014US20140127315 Caudal Salve
05/08/2014US20140127311 Bio-compatible nano-polymer particles comprising active ingredients for pulmonary application
05/08/2014US20140127310 Treatment of disease with poly-n-acetylglucosamine nanofibers
05/08/2014US20140127304 Process for preparing solid amorphous particles comprising tiotropium bromide and a co-solid
05/08/2014US20140127302 Analgesic Pharmaceutical Composition For Oral Administration
05/08/2014US20140127300 Abuse resistant drug forms
05/08/2014US20140127295 Compositions, process of preparation of said compositions and method of treating inflammatory diseases
05/08/2014US20140127294 Oral solid formulation of compound anti-tubercular drug and preparation method thereof
05/08/2014US20140127292 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
05/08/2014US20140127291 Extended release acetaminophen liquid pharmaceutical compositions
05/08/2014US20140127289 Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
05/08/2014US20140127287 Liposome-encapsulated hydrogels for use in a drug delivery system
05/08/2014US20140127284 Micro-rnas and micro-rna inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
05/08/2014US20140127281 Propynylaminoindan transdermal compositions
05/08/2014US20140127280 Intrauterine delivery system for contraception
05/08/2014US20140127278 Method Of Treating Vascular Disease In Diabetic Patients
05/08/2014US20140127255 Chimeric immunomodulatory compounds and methods of using the same-iv
05/08/2014US20140127253 Biodegradable particulate formulations
1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 7860